Literature DB >> 8960828

Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control.

J L Sánchez-Quesada1, A Pérez, A Caixàs, J Ordónmez-Llanos, G Carreras, A Payés, F González-Sastre, A de Leiva.   

Abstract

We evaluated the effect of improving glycaemic control with intensive insulin therapy on LDL susceptibility to oxidation, electronegative LDL proportion, and LDL subfraction phenotype in a group of 25 patients with short-duration insulin-dependent diabetes mellitus (IDDM); 25 matched healthy control subjects were also studied. LDL susceptibility to oxidation was measured by continuous monitoring of conjugated diene formation. Electronegative LDL was isolated by anion exchange chromatography, and quantified as percentage of total LDL. Six LDL subfractions were isolated by density gradient ultracentrifugation and phenotype A or B classified as the quotient (LDL1-LDL3)/(LDL4-LDL6). Compared to the control group, IDDM subjects with poor glycaemic control showed higher electronegative LDL (19.03 +/- 10.09 vs 9.59 +/- 2.98%, p < 0.001), similar LDL subfraction phenotype and lower susceptibility to oxidation (lag phase 45.6 +/- 8.8 vs 41.2 +/- 4.7 min, p < 0.05). After three months of intensive insulin therapy, HbA1c decreased from 10.88 +/- 2.43 to 5.69 +/- 1.54% (p < 0.001), and electronegative LDL to 13.84 +/- 5.15% (p < 0.05). No changes in LDL susceptibility to oxidation or LDL subfraction phenotype were observed. Electronegative LDL appeared significantly correlated to HbA1c and fructosamine (p < 0.01 and p < 0.001) only in poorly controlled IDDM patients. These findings suggest that high electronegative LDL in IDDM subjects is related to the degree of glycaemic control, and could therefore be due to LDL glycation rather than to LDL oxidation or changes in LDL subfraction phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8960828     DOI: 10.1007/s001250050600

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  12 in total

1.  SNP3 polymorphism in apo A-V gene is associated with small dense LDL particles in Type 2 diabetes.

Authors:  E Esteve; E Faure; F Calvo; E Aguillo; C Blasco; M J Roche; P Mozas; M Pocovi
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

2.  HDL and electronegative LDL exchange anti- and pro-inflammatory properties.

Authors:  Cristina Bancells; José Luis Sánchez-Quesada; Ragnhild Birkelund; Jordi Ordóñez-Llanos; Sònia Benítez
Journal:  J Lipid Res       Date:  2010-07-20       Impact factor: 5.922

3.  Negatively charged low-density lipoprotein is associated with atherogenic risk in hypertensive patients.

Authors:  Jungo Urata; Satoshi Ikeda; Seiji Koga; Tomoo Nakata; Tomohiko Yasunaga; Koichiro Sonoda; Yuji Koide; Naoto Ashizawa; Shigeru Kohno; Koji Maemura
Journal:  Heart Vessels       Date:  2011-04-14       Impact factor: 2.037

4.  The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity.

Authors:  J L Sánchez-Quesada; S Benítez; A Pérez; A M Wagner; M Rigla; G Carreras; L Vila; M Camacho; R Arcelus; J Ordóñez-Llanos
Journal:  Diabetologia       Date:  2005-08-18       Impact factor: 10.122

5.  Preparation of LDL , Oxidation , Methods of Detection, and Applications in Atherosclerosis Research.

Authors:  Chandrakala Aluganti Narasimhulu; Sampath Parthasarathy
Journal:  Methods Mol Biol       Date:  2022

6.  LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein.

Authors:  Liana Asatryan; Ryan T Hamilton; J Mario Isas; Juliana Hwang; Rakez Kayed; Alex Sevanian
Journal:  J Lipid Res       Date:  2004-10-16       Impact factor: 5.922

Review 7.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

8.  Generation in human plasma of misfolded, aggregation-prone electronegative low density lipoprotein.

Authors:  Giulia Greco; Gabor Balogh; Roberto Brunelli; Graziella Costa; Marco De Spirito; Laura Lenzi; Giampiero Mei; Fulvio Ursini; Tiziana Parasassi
Journal:  Biophys J       Date:  2009-07-22       Impact factor: 4.033

9.  Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein.

Authors:  Liang-Yin Ke; David A Engler; Jonathan Lu; Risë K Matsunami; Hua-Chen Chan; Guei-Jane Wang; Chao-Yuh Yang; Jan-Gowth Chang; Chu-Huang Chen
Journal:  Pure Appl Chem       Date:  2011       Impact factor: 2.453

10.  Dual roles for lipolysis and oxidation in peroxisome proliferation-activator receptor responses to electronegative low density lipoprotein.

Authors:  Ouliana Ziouzenkova; Liana Asatryan; Deanna Sahady; Gabriela Orasanu; Stephan Perrey; Benjamin Cutak; Tom Hassell; Taro E Akiyama; Joel P Berger; Alex Sevanian; Jorge Plutzky
Journal:  J Biol Chem       Date:  2003-07-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.